Loading...

Greg Angstreich, MD

Title(s)Associate Professor of Clinical Medicine
Address520 Superior Avenue, Suite 300
Health Sciences Campus
Newport Beach CA 92663
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Angstreich completed a Medical Oncology and Hematology Fellowship at the Johns Hopkins Hospital Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, from 2001-2004. His formal medical training began with the Traditional Internal Medicine Internship and Residency Program at Barnes-Jewish Hospital in St. Louis, Missouri, from 1997-2000.

    Additionally, he graduated with College Honors from Washington University in 1993 and with a Letter of Commendation from Washington University School of Medicine in 1997, both in St. Louis, Missouri.
    Dr. Angstreich is a member of the American Society of Clinical Oncology and the American Society of Hematology. He is also Board Certified in Internal Medicine, Hematology and Medical Oncology and has vast experience treating all malignancies, as well as all benign and cancerous blood disorders.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors. Br J Haematol. 2005 Aug; 130(3):373-81. Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith BD, Jones RJ. PMID: 16042686.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    2. Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant. Curr Opin Oncol. 2004 Mar; 16(2):95-9. Angstreich GR, Smith BD, Jones RJ. PMID: 15075898.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans